# Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice

> **NCT01186133** · — · RECRUITING · sponsor: **Seung-Jung Park** · enrollment: 50000 (estimated)

## Conditions studied

- Coronary Artery Disease
- Percutaneous Transluminal Coronary Angioplasty

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01186133
- **Lead sponsor:** Seung-Jung Park
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2009-01
- **Primary completion:** 2030-12
- **Final completion:** 2030-12
- **Target enrollment:** 50000 (ESTIMATED)
- **Last updated:** 2025-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01186133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01186133, "Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01186133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*